Precocious and delayed puberty. Studies of FSH and LH production and metabolism

1980 ◽  
Vol 94 (4) ◽  
pp. 475-479 ◽  
Author(s):  
Salvatore Raiti ◽  
Noel K. Maclaren ◽  
F. A. Akesode
Keyword(s):  
Sexual Development ◽  
The Other ◽  
Delayed Puberty ◽  
Plasma Testosterone ◽  
Metabolic Clearance ◽  
Early Puberty ◽  
Hypogonadotrophic Hypogonadism ◽  
Constitutional Delay ◽  
Excretion Rates ◽  
End Of Puberty

Abstract. We measured the production rates and metabolic clearance, disappearance and excretion rates of FSH and LH as well as plasma testosterone and Δ4androstenedione in males with precocious and delayed puberty. In precocious puberty, we found modestly elevated FSH production early in puberty, reaching adult levels by midpuberty and remaining constant thereafter. LH production was low early in puberty, reached high levels at midpuberty and then fell. The plasma testosterone concentrations paralleled the changes in LH. This suggests that moderate FSH production is achieved by early puberty and adult levels are reached by midpuberty. On the other hand LH production is low early in puberty, reaches high levels by midpuberty and then falls again towards the end of puberty. Constitutional delay in sexual development probably consists of several syndromes due either to a delay in LH production or to FSH production or to both. One patient with hypogonadotrophic hypogonadism was also studied. He showed relatively normal LH production but very low FSH production.

Normal Sexual Development and Puberty

2021 ◽  
Author(s):  
Amanda French
Keyword(s):  
Sexual Development ◽  
Sex Steroids ◽  
Pubertal Development ◽  
Follicle Stimulating Hormone ◽  
Growth Spurt ◽  
Delayed Puberty ◽  
Health Issues ◽  
Reproductive Axis ◽  
Physical Changes ◽  
End Of Puberty

Puberty is the hormonally mediated process of physical changes that occur during the transition of childhood to adulthood.   Activation of the hypothalamic-pituitary-gonadal axis triggers the onset of puberty. Gonadotropin hormone-releasing hormone (GnRH) is the major regulator of the reproductive axis.  GnRH stimulates the anterior pituitary gland to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which in turn activate the gonads to produce sex steroids. Thelarche is stimulated by estrogen and is usually the first sign of puberty in girls. Adrenarche, although associated temporally with puberty, is mediated by the adrenal cortex and is unrelated to pubertal maturation. A growth spurt occurs mid-puberty.  Menarche, usually occurring 2-3 years after thelarche, is considered the end of puberty. After menarche, only about 1-2 additional inches of height are accrued.  Understanding what is considered the normal timeline of sexual development allows better recognition of precocious or delayed puberty, both of which may be associated with serious underlying health issues This review contains 4 tables, 5 figures, and 29 references. Keywords: puberty, pubertal development, hypothalamic-pituitary-gonadal axis, thelarche, menarche, normal sexual development

Breeding

1931 ◽  
Vol 4 (2) ◽  
pp. 17-28
Keyword(s):  
Body Weight ◽  
The Netherlands ◽  
Point Of View ◽  
The Other ◽  
White Leghorn ◽  
Early Puberty

Investigation into the differences between Barneveld and White Leghorn breeds from a genetical and breeding technic point of view. Report to the Committee of the Netherlands Genetic Society regarding breeding tests with poultry in 1926–1927 and 1928–1929. A. L. Hagedoorn. Züchtungskunde, 1930, p.450.The investigation was carried out in four directions: 1) It was to be ascertained whether a correlation exists between various continuing characteristics appearing in combination in two breeds of poultry (Aziatic and Meditteranean breeds) (coloured eggs, white eggs, white ears, light body weight and early puberty in the other). 2) It was to be investigated whether it was possible to incorporate the qualities of „Brown Egg” and „Early Puberty” in a good laying utility breed. 3) The question was to be treated what gens have influence on the colour of the egg, the colour of the plumage, the colour of the feet etc. 4) Finally data, relating to the value of cross-breeds and their progeny as utility poultry were to be gathered.

Delayed Puberty

2020 ◽  
Author(s):  
Amanda French
Keyword(s):  
Pubertal Timing ◽  
Hormone Replacement ◽  
Hypogonadotropic Hypogonadism ◽  
Disease Process ◽  
Optimal Growth ◽  
Underlying Disease ◽  
Delayed Puberty ◽  
Hypergonadotropic Hypogonadism ◽  
Pubertal Delay ◽  
Constitutional Delay

Although common, delayed puberty can be distressing to patients and families.   Careful assessment is necessary to ensure appropriate physical and social development in patients that require intervention to reach pubertal milestones and achieve optimal growth.  Most pubertal delay is from lack of activation of the hypothalamic-pituitary-gonadal axis which then results in a functional or physiologic GnRH deficiency.  The delay may be temporary or permanent.  Constitutional delay (CDGP), also referred to as self-limited delayed puberty (DP), describes children on the extreme end of normal pubertal timing and is the most common cause of delayed puberty, representing about one third of cases.  Hypergonadotropic hypogonadism (primary hypogonadism) results from a failure of the gonad itself, and hypogonadotropic hypogonadism (secondary hypogonadism) results from a failure of the hypothalamic-pituitary axis, which is usually caused by another process, often systemic.  Diagnosis is based on history and examination.  Treatment is based on the underlying cause of pubertal delay and may include hormone replacement.  Involving a pediatric endocrinologist should be considered.  Appropriate counseling and ongoing support are important for all patients and families, regardless of underlying disease process.   This review contains 4 figures, 4 tables, and 32 references. Keywords: puberty, delayed puberty, hypogonadism, hypogonadotropic hypogonadism, hypergonadotropic hypogonadism, menarche, thelarche, constitutional delay and growth in puberty, Turner syndrome

Half-life, hemodynamic, renal, and hormonal effects of prorenin in cynomolgus monkeys

1991 ◽  
Vol 260 (4) ◽  
pp. R804-R810 ◽  
Author(s):  
T. Lenz ◽  
J. E. Sealey ◽  
T. Maack ◽  
G. D. James ◽  
R. L. Heinrikson ◽  
...  
Keyword(s):  
Half Life ◽  
Renal Plasma Flow ◽  
Plasma Renin ◽  
Apparent Volume ◽  
Reproductive Organs ◽  
Volume Of Distribution ◽  
Plasma Testosterone ◽  
Metabolic Clearance ◽  
Cynomolgus Monkeys ◽  
Pharmacokinetic Properties

Prorenin is found in human plasma, kidneys, and reproductive organs. We investigated the physiological and pharmacokinetic properties of plasma prorenin, and its plasma conversion to active renin, by bolus infusions of human recombinant prorenin (0.5, 2, 20 micrograms; n = 4/dose) into anesthetized male cynomolgus monkeys. The infused prorenin had 3% intrinsic renin activity. Plasma prorenin rose from 61 +/- 6 to 101 +/- 11, 570 +/- 46, and 7,700 +/- 390 ng.ml-1.h-1, respectively, after 5 min. Plasma renin increased to 3% of total renin, angiotensin II increased less than twofold, and aldosterone did not change. Plasma testosterone fell slightly (P less than 0.01). Mean arterial pressure (MAP) fell slowly from 104 +/- 3 to 93 +/- 3 mmHg at 60 min (P less than 0.001). Heart rate, glomerular filtration rate, renal plasma flow, and urinary sodium and potassium excretion were unchanged. For the 2- and 20-micrograms doses, respectively, effective half-life of plasma decay was 47 +/- 4.9 and 109 +/- 21 min (P less than 0.05), apparent volume of distribution was 145 +/- 11 and 166 +/- 35 ml/kg, and metabolic clearance rate was 2.30 +/- 0.44 and 1.08 +/- 0.14 ml.min-1.kg-1 (P less than 0.01). In conclusion, neither the hormonal nor the physiological response to infusion of pharmacologic levels of recombinant human prorenin into monkeys provide evidence for conversion of circulating prorenin to renin. MAP did not increase and actually fell without commensurate effects on renal function. The half-life of recombinant prorenin was similar to that of renin.

Gonadal function after surgery and chemotherapy in men with stage II and III nonseminomatous testicular tumors.

1987 ◽  
Vol 5 (4) ◽  
pp. 651-656 ◽  
Author(s):  
J M Nijman ◽  
H Schraffordt Koops ◽  
J Kremer ◽  
D T Sleijfer
Keyword(s):  
Semen Analysis ◽  
Residual Tumor ◽  
The Other ◽  
Stage I ◽  
Retroperitoneal Lymph Node Dissection ◽  
Plasma Testosterone ◽  
Healthy Children ◽  
Testicular Tumors ◽  
Testosterone Levels ◽  
Lower Limit Of Normal

The gonadal functions were studied in 54 patients with disseminated nonseminomatous testicular tumors who had been subjected to combination chemotherapy (cisplatin, vinblastine, and bleomycin [PVB]) and surgery (hemiorchiectomy, retroperitoneal lymph node dissection or removal of retroperitoneal residual tumor after chemotherapy) and in 17 patients with a stage I tumor subjected to hemiorchiectomy exclusively. In the patients treated with chemotherapy, the plasma testosterone levels remained at the lower limit of normal and the luteinizing hormone (LH) levels remained elevated for 2 years after completion of treatment. The follicle-stimulating hormone (FSH) levels also remained significantly elevated, but showed a tendency to decrease after 2 years. Semen analysis was performed in 25 patients; of the other patients, 18 had no antegrade ejaculation, eight had undergone a vasectomy and three patients did not cooperate. Before treatment, 72% of the patients showed azoo- or oligozoospermia; 2 years after discontinuation of the chemotherapy, 48% had azoo- or oligozoospermia while 28% had more than 60 X 10(6) spermatozoa/mL. However, interestingly the proportion of patients with azoospermia had increased from 4% to 28%. In the course of this study, eight pregnancies occurred; one ended in an early spontaneous abortion; the other seven pregnancies ran an uncomplicated course. Seven healthy children were born. In 17 patients with a stage I tumor treated by hemiorchiectomy only, the testosterone, LH and FSH levels were also observed for 2 years; until 2 years after treatment, the testosterone levels remained lower and the FSH levels remained higher than normal. Insufficiency of the Leydig's cells in the unaffected gonad appeared to be responsible for the altered hormone concentrations in the blood.

scholarly journals Age-Related Alterations in Pituitary and Testicular Functions in Long-Lived Growth Hormone Receptor Gene-Disrupted Mice

Endocrinology ◽  
2007 ◽  
Vol 148 (12) ◽  
pp. 6019-6025 ◽  
Author(s):  
Varadaraj Chandrashekar ◽  
Christina R. Dawson ◽  
Eric R. Martin ◽  
Juliana S. Rocha ◽  
Andrzej Bartke ◽  
...  
Keyword(s):  
Growth Hormone Receptor ◽  
Receptor Gene ◽  
Delayed Puberty ◽  
Plasma Testosterone ◽  
Mrna Levels ◽  
Testosterone Levels ◽  
Gh Receptor ◽  
Age Related ◽  
Igf I ◽  
Plasma Prl

The somatotropic axis, GH, and IGF-I interact with the hypothalamic-pituitary-gonadal axis in health and disease. GH-resistant GH receptor-disrupted knockout (GHRKO) male mice are fertile but exhibit delayed puberty and decreases in plasma FSH levels, testicular content of LH, and prolactin (PRL) receptors, whereas PRL levels are elevated. Because the lifespan of GHRKO mice is much greater than the lifespan of their normal siblings, it was of interest to compare age-related changes in the hypothalamic-pituitary-gonadal axis in GHRKO and normal animals. Plasma IGF-I, insulin, PRL, LH, FSH, androstenedione and testosterone levels, and acute responses to GnRH and LH were measured in young (2–4 and 5–6 months of age) and old (18–19 and 23–26 months of age) male GHRKO mice and their normal siblings. Plasma IGF-I was not detectable in GHRKO mice. Plasma PRL levels increased with age in normal mice but declined in GHRKO males, and did not differ in old GHRKO and normal animals. Plasma LH responses to acute GnRH stimulation were attenuated in GHRKO mice but increased with age only in normal mice. Plasma FSH levels were decreased in GHRKO mice regardless of age. Plasma testosterone responses to LH stimulation were attenuated in old mice regardless of genotype, whereas plasma androstenedione responses were reduced with age only in GHRKO mice. Testicular IGF-I mRNA levels were normal in young and increased in old GHRKO mice, whereas testicular concentrations and total IGF-I levels were decreased in these animals. These findings indicate that GH resistance due to targeted disruption of the GH receptor gene in mice leads to suppression of testicular IGF-I levels, and modifies the effects of aging on plasma PRL levels and responses of the pituitary and testes to GnRH and LH stimulation. Plasma testosterone levels declined during aging in normal but not in GHRKO mice, and the age-related increase in the LH responses to exogenous GnRH was absent in GHRKO mice, perhaps reflecting a delay of aging in these remarkably long-lived animals.

Changes in androgen concentrations during puberty and their relation to behaviour in male Saccostomus campestris (Gray 1844), an African rodent

1993 ◽  
Vol 5 (5) ◽  
pp. 577 ◽  
Author(s):  
LM Westlin ◽  
HM Dott
Keyword(s):  
Sexual Development ◽  
Plasma Concentrations ◽  
Reproductive Organs ◽  
Oestrous Cycle ◽  
Plasma Testosterone ◽  
Seminiferous Tubules ◽  
Morphological Development ◽  
Intraindividual Variation ◽  
Adult Females ◽  
Tubule Diameter

Sexual development in male Saccostomus campestris, the pouched mouse, was studied in terms of morphological development and changes in concentrations of plasma testosterone and androstenedione. The interaction of adult females and males following the introduction of a male was observed at all stages of the oestrous cycle. The histology of the reproductive organs is similar to that of other rodents. Measurements of the diameter of the seminiferous tubules and the width of the seminiferous epithelium suggest asymptotic growth but, although the diameter had not reached the asymptote at 70 days of age the epithelial width was close to the calculated asymptote at 55 days of age. Intraindividual variation was no greater than variation between individuals of the same age from 55-70 days. Spermatids were not seen in any animals younger than 45 days, but all animals over 55 days of age had spermatozoa in the epididymis. By 70 days of age, fertile matings were observed. At this stage, the seminiferous tubule diameter was still increasing slowly but plasma concentrations of testosterone and androstenedione had reached adult levels; at no time was the concentration of testosterone greater than androstenedione. The males were never aggressive towards females; however, they were severely attacked by females at all stages of the oestrous cycle except pro-oestrus. Only rarely did males show aggression to other males.

Estimation of growth hormone secretion rate: impact of kinetic assumptions intrinsic to the analytical approach

2001 ◽  
Vol 280 (1) ◽  
pp. R225-R232 ◽  
Author(s):  
Janneke G. Langendonk ◽  
Johannes D. Veldhuis ◽  
Jacobus Burggraaf ◽  
Rik C. Schoemaker ◽  
Adam F. Cohen ◽  
...  
Keyword(s):  
Growth Hormone ◽  
Analytical Approach ◽  
Normal Weight ◽  
Secretion Rate ◽  
The Other ◽  
Upper Body ◽  
Metabolic Clearance ◽  
Obese Women ◽  
Gh Secretion ◽  
Plasma Gh

We compared four common mathematical techniques to determine daily endogenous growth hormone (GH) secretion rates from diurnal plasma GH concentration profiles in 24 women (16 upper- or lower-body obese and 8 normal-weight individuals). Two forms of deconvolution analysis and two techniques based on a priori determined GH clearance estimates were employed. Deconvolution analyses revealed significant differences in the 24-h GH secretion rate between normal-weight and upper-body obese women, whereas the other two techniques did not. Moreover, deconvolution analyses predicted that the reduction in mean plasma GH concentrations in upper-body obese women was accounted for by impaired GH secretion, whereas the other methods suggested that obesity increases GH metabolic clearance. Thus we infer that disparate conclusions concerning GH secretion can be drawn from the same primary data set. The different inferences likely reflect dissimilar kinetic assumptions and the particular limitations intrinsic to each analytical approach. Accordingly, we urge caution in the facile comparison of calculated GH secretion data in humans, especially when kinetic and secretion measurements are performed under different conditions. The most appropriate way to determine the GH secretion rate in humans must be balanced by the exact intent of the experiment and the acceptability of different assumptions in that context.

scholarly journals Möbius syndrome associated with obesity and precocious puberty

2018 ◽  
Vol 11 (1) ◽  
pp. e219590
Author(s):  
Samantha Roshani De Silva ◽  
Sally L Painter ◽  
Darius Hildebrand
Keyword(s):  
Precocious Puberty ◽  
Neurological Disorder ◽  
Cranial Nerves ◽  
Delayed Puberty ◽  
Hypogonadotrophic Hypogonadism ◽  
Möbius Syndrome ◽  
Hypothalamic Pituitary Axis

Möbius syndrome is a neurological disorder involving underdevelopment of the sixth and seventh cranial nerves. Multiple associations have been described including dysfunction of other cranial nerves, limb abnormalities and hypogonadotrophic hypogonadism causing delayed puberty. We present the second reported case of Möbius syndrome associated with obesity and with precocious puberty. These features may be secondary to dysregulation of the hypothalamic–pituitary axis. We highlight the need to consider extraocular symptoms in these patients and for close liaison with physicians in their management.

Sign in / Sign up

Export Citation Format

Share Document